NO994042L - Transdermal anordning til levering av testosteron - Google Patents
Transdermal anordning til levering av testosteronInfo
- Publication number
- NO994042L NO994042L NO994042A NO994042A NO994042L NO 994042 L NO994042 L NO 994042L NO 994042 A NO994042 A NO 994042A NO 994042 A NO994042 A NO 994042A NO 994042 L NO994042 L NO 994042L
- Authority
- NO
- Norway
- Prior art keywords
- testosterone
- delivery
- transdermal device
- transdermal
- terpene
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title abstract 4
- 229960003604 testosterone Drugs 0.000 title abstract 2
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 150000003505 terpenes Chemical class 0.000 abstract 1
- 235000007586 terpenes Nutrition 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Det er beskrevet en transdermal leveringsanordning som inkluderer et klebelag som inneholder en terapeutisk effektiv mengde av testosteron og et leveringsfremmende adjuvans som omfatter terpen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3927497P | 1997-02-28 | 1997-02-28 | |
PCT/US1998/003943 WO1998037871A1 (en) | 1997-02-28 | 1998-02-27 | Transdermal device for the delivery of testosterone |
Publications (2)
Publication Number | Publication Date |
---|---|
NO994042D0 NO994042D0 (no) | 1999-08-20 |
NO994042L true NO994042L (no) | 1999-10-26 |
Family
ID=21904596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994042A NO994042L (no) | 1997-02-28 | 1999-08-20 | Transdermal anordning til levering av testosteron |
Country Status (16)
Country | Link |
---|---|
US (1) | US6132760A (no) |
EP (1) | EP0979072B1 (no) |
JP (1) | JP2001517216A (no) |
KR (1) | KR20000075804A (no) |
AT (1) | ATE293960T1 (no) |
AU (1) | AU735944B2 (no) |
BR (1) | BR9807786A (no) |
CA (1) | CA2281876A1 (no) |
DE (1) | DE69829961T2 (no) |
HU (1) | HUP0001748A3 (no) |
NO (1) | NO994042L (no) |
NZ (1) | NZ337135A (no) |
PL (1) | PL335410A1 (no) |
SK (1) | SK116199A3 (no) |
TR (1) | TR199902104T2 (no) |
WO (1) | WO1998037871A1 (no) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2793689B1 (fr) * | 1999-05-19 | 2001-08-24 | Pf Medicament | Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives |
US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
US6586000B2 (en) | 1999-12-16 | 2003-07-01 | Dermatrends, Inc. | Hydroxide-releasing agents as skin permeation enhancers |
US6562369B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers |
US6582724B2 (en) * | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
JP2004509222A (ja) * | 2000-09-19 | 2004-03-25 | ナショナル スターチ アンド ケミカル インベストメント ホールディング コーポレイション | 経皮薬物送達システムにおいて有用な非反応型接着剤 |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
CA2446619C (en) * | 2001-05-11 | 2011-04-26 | Elan Corporation, Plc | Permeation enhancers |
KR100517637B1 (ko) * | 2001-12-21 | 2005-09-28 | 씨제이 주식회사 | 섬수 정제 엑스 및 인삼 정제 엑스를 함께 함유하면서다른 정유 생약 성분은 함유하지 않는 조루증의 예방 및치료용 조성물 |
US20040062794A1 (en) * | 2002-09-30 | 2004-04-01 | Lee Shulman | 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy |
IL152575A (en) * | 2002-10-31 | 2008-12-29 | Transpharma Medical Ltd | A skin-to-skin transmission system of water-insoluble drugs |
IL152573A (en) * | 2002-10-31 | 2009-11-18 | Transpharma Medical Ltd | A system for the transmission through the skin of a medical preparation against vomiting and nausea |
KR101159828B1 (ko) | 2003-04-30 | 2012-07-04 | 퍼듀 퍼머 엘피 | 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형 |
US8790689B2 (en) * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
US20040259852A1 (en) * | 2003-06-18 | 2004-12-23 | White Hillary D. | Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
US8883769B2 (en) * | 2003-06-18 | 2014-11-11 | White Mountain Pharma, Inc. | Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
EP1643946A2 (en) * | 2003-06-20 | 2006-04-12 | Viral Genomix, Inc. | Compositions for and methods for treating hiv |
WO2005049090A2 (en) * | 2003-11-18 | 2005-06-02 | 3M Innovative Properties Company | Olanzapine containing transdermal drug delivery compositions |
JP4567998B2 (ja) * | 2004-03-22 | 2010-10-27 | コスメディ製薬株式会社 | 親水性粘着剤を用いた親水性皮膚外用粘着剤組成物および親水性貼付剤 |
TR201815853T4 (tr) | 2005-10-12 | 2018-11-21 | Besins Healthcare Sarl | Hipogonadizmin tedavisinde kullanıma yönelik geliştirilmiş testosteron jeli. |
US20080132475A1 (en) * | 2006-12-05 | 2008-06-05 | Charles Gerald Connor | Treatment for dry eye |
US20100016264A1 (en) * | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
FR2924942B1 (fr) * | 2007-12-14 | 2012-06-15 | Pf Medicament | Compositions pharmaceutiques transcutanees contenant une hormone steroidienne |
US8445037B2 (en) * | 2008-10-28 | 2013-05-21 | A. M. Todd Company | Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest |
AU2011329782A1 (en) | 2010-11-18 | 2013-06-20 | White Mountain Pharma, Inc. | Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein |
EP3083862B1 (en) * | 2013-12-20 | 2020-08-05 | 3M Innovative Properties Company | Antimicrobial pressure-sensitive adhesive system |
UY35923A (es) * | 2013-12-30 | 2015-07-31 | Rhodia Operations | ?composiciones pesticidas agrícolas?. |
US11813354B1 (en) | 2019-01-11 | 2023-11-14 | Shear Kershman Laboratories, Inc | Trans-mucosal delivery system for testosterone |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU622162B2 (en) * | 1988-04-22 | 1992-04-02 | Ciba-Geigy Ag | Transdermal monolith systems |
AU6712090A (en) * | 1989-10-13 | 1991-05-16 | Watson Laboratories, Inc. | Drug delivery systems and matrix therefor |
US5240932A (en) * | 1990-03-30 | 1993-08-31 | Yasunori Morimoto | Percutaneously absorbable compositions of morphine or analogous analgesics of morphine |
US5164190A (en) * | 1990-12-11 | 1992-11-17 | Theratech, Inc. | Subsaturated transdermal drug delivery device exhibiting enhanced drug flux |
US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
EP0491076A1 (en) * | 1990-12-19 | 1992-06-24 | Theratech, Inc. | Penetration enhancement with multi-component system of N-aliphatic pyrrolidones with lower alcohols |
US5340586A (en) * | 1991-04-12 | 1994-08-23 | University Of Southern California | Methods and formulations for use in treating oophorectomized women |
US5211952A (en) * | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
US5676968A (en) * | 1991-10-31 | 1997-10-14 | Schering Aktiengesellschaft | Transdermal therapeutic systems with crystallization inhibitors |
US5230897A (en) * | 1991-10-31 | 1993-07-27 | G. D. Searle & Co. | Transdermal pentamidine |
CA2075517C (en) * | 1992-04-01 | 1997-03-11 | John Wick | Transdermal patch incorporating a polymer film incorporated with an active agent |
JP3548195B2 (ja) * | 1993-05-27 | 2004-07-28 | リンテック株式会社 | 経皮吸収型製剤 |
US5460820B1 (en) * | 1993-08-03 | 1999-08-03 | Theratech Inc | Method for providing testosterone and optionally estrogen replacement therapy to women |
JP3908795B2 (ja) * | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | ケトチフェン含有経皮投与製剤 |
-
1998
- 1998-02-27 PL PL98335410A patent/PL335410A1/xx unknown
- 1998-02-27 JP JP53791698A patent/JP2001517216A/ja active Pending
- 1998-02-27 TR TR1999/02104T patent/TR199902104T2/xx unknown
- 1998-02-27 SK SK1161-99A patent/SK116199A3/sk unknown
- 1998-02-27 NZ NZ337135A patent/NZ337135A/en unknown
- 1998-02-27 AU AU65390/98A patent/AU735944B2/en not_active Ceased
- 1998-02-27 US US09/031,619 patent/US6132760A/en not_active Expired - Lifetime
- 1998-02-27 EP EP98911439A patent/EP0979072B1/en not_active Expired - Lifetime
- 1998-02-27 AT AT98911439T patent/ATE293960T1/de not_active IP Right Cessation
- 1998-02-27 DE DE69829961T patent/DE69829961T2/de not_active Expired - Fee Related
- 1998-02-27 WO PCT/US1998/003943 patent/WO1998037871A1/en active IP Right Grant
- 1998-02-27 HU HU0001748A patent/HUP0001748A3/hu unknown
- 1998-02-27 KR KR1019997007877A patent/KR20000075804A/ko not_active Application Discontinuation
- 1998-02-27 CA CA002281876A patent/CA2281876A1/en not_active Abandoned
- 1998-02-27 BR BR9807786-4A patent/BR9807786A/pt not_active IP Right Cessation
-
1999
- 1999-08-20 NO NO994042A patent/NO994042L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO994042D0 (no) | 1999-08-20 |
JP2001517216A (ja) | 2001-10-02 |
EP0979072B1 (en) | 2005-04-27 |
AU6539098A (en) | 1998-09-18 |
TR199902104T2 (xx) | 2000-04-21 |
ATE293960T1 (de) | 2005-05-15 |
DE69829961T2 (de) | 2006-02-23 |
NZ337135A (en) | 2001-07-27 |
HUP0001748A2 (hu) | 2000-12-28 |
EP0979072A1 (en) | 2000-02-16 |
CA2281876A1 (en) | 1998-09-03 |
BR9807786A (pt) | 2000-02-22 |
DE69829961D1 (de) | 2005-06-02 |
KR20000075804A (ko) | 2000-12-26 |
PL335410A1 (en) | 2000-04-25 |
SK116199A3 (en) | 2000-01-18 |
AU735944B2 (en) | 2001-07-19 |
US6132760A (en) | 2000-10-17 |
HUP0001748A3 (en) | 2001-03-28 |
WO1998037871A1 (en) | 1998-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO994042L (no) | Transdermal anordning til levering av testosteron | |
CA2278714A1 (en) | Externally mounted medicated nasal dilator | |
ES2152979T3 (es) | Sistema terapeutico transdermal que contiene estradiol. | |
PL324552A1 (en) | Plaster for pecutaneous administration of hormones | |
AU2895392A (en) | Transdermal therapeutic systems containing crystallization inhibitors | |
GB2333474A (en) | Method and apparatus for the coating of substrates for pharmaceutical use | |
DK0973497T3 (da) | Farmaceutisk bæreanordning, egnet til udlevering af farmaceutiske forbindelser til slimhindeoverflade | |
ES2147858T3 (es) | Matriz para el suministro transdermico de farmacos. | |
ZA977832B (en) | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents. | |
ATE206905T1 (de) | Pflaster | |
AU4948493A (en) | Dexpanthenol-containing plaster for the transdermal application of steroid hormones | |
WO2001050989A8 (en) | Pliable contact bandage | |
ES2156220T3 (es) | Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica. | |
NO20000921L (no) | Fibrinogenbasert vevklebemiddel | |
AU4657896A (en) | Polyisobutylene adhesives containing high TG tackifier for transdermal devices | |
NO993855L (no) | Töyelig transdermalt terapeutisk system | |
NO993435L (no) | Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon | |
HUP9903340A2 (hu) | Trimegeszton transzdermális adagolására szolgáló új eszköz, és eljárás előállítására | |
DK0767831T3 (da) | Sprøjte omfattende et vedhæftende substrat for mikrober | |
WO1996008237A3 (de) | Selbstklebendes pflaster zur abgabe von wirkstoff an die umgebung eines trägers | |
AU4015097A (en) | Transdermal therapeutic system having an active compound combination comprising oestriol | |
ES2118690T3 (es) | Disco de control para un arrollador de cinturon. | |
IT8720952A0 (it) | Dispositivo perfezionato per applicare etichette adesive erelativo procedimento operativo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |